|
FAM119B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.642100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.541100E-03 |
| Normal-vs-Stage2 |
5.632200E-02 |
| Normal-vs-Stage3 |
2.219800E-01 |
| Normal-vs-Stage4 |
6.050200E-01 |
| Stage1-vs-Stage2 |
8.230600E-01 |
| Stage1-vs-Stage3 |
2.296200E-01 |
| Stage1-vs-Stage4 |
2.013800E-01 |
| Stage2-vs-Stage3 |
5.100200E-01 |
| Stage2-vs-Stage4 |
3.412400E-01 |
| Stage3-vs-Stage4 |
6.974400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.158400E-03 |
| Normal-vs-AfricanAmerican |
4.233800E-02 |
| Normal-vs-Asian |
9.523900E-02 |
| Caucasian-vs-AfricanAmerican |
6.531000E-01 |
| Caucasian-vs-Asian |
4.519000E-01 |
| AfricanAmerican-vs-Asian |
4.228600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.196900E-04 |
| Normal-vs-Female |
1.513410E-01 |
| Male-vs-Female |
9.582200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.777800E-03 |
| Normal-vs-Extreme_Weight |
5.575500E-04 |
| Normal-vs-Obese |
8.964200E-02 |
| Normal-vs-Extreme_Obese |
2.029900E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.521200E-01 |
| Normal_Weight-vs-Obese |
2.149200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.198800E-01 |
| Extreme_Weight-vs-Obese |
4.278200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.733000E-01 |
| Obese-vs-Extreme_Obese |
2.055600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.337400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.049510E-02 |
| Normal-vs-Age(61-80Yrs) |
6.637200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.739400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.850000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.992000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.994200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.161170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.226600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.242600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.142700E-03 |
| Normal-VS-Type2 PRCC |
3.21660000002222E-06 |
| Normal-VS-KIRP CIMP |
1.145440E-01 |
| Normal-VS-Unclassified PRCC |
4.335400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.758500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.020000E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.784100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.797400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.359100E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.729600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.164310E-03 |
| Normal-vs-N1 |
5.697400E-01 |
| Normal-vs-N2 |
7.198400E-01 |
| N0-vs-N1 |
6.746200E-02 |
| N0-vs-N2 |
2.492200E-01 |
| N1-vs-N2 |
9.694400E-01 |
|
|
